MedTrace Logo

Use of Incretins in Diabetic Patients

NCT03486964 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2234

Last updated 2022-05-24

No results posted yet for this study

Summary

Observational, retrospective study, conducted in diabetic patients aimed to evaluate the effects on the glyco-metabolic control and on cardiovascular events of different DPP-4 inhibitors. Patients will be stratified in patients taking different DPP-4 in addition to sulfonylureas, biguanides, thiazolidinediones, insulin, compared to those in therapy with other hypoglycemic classes, such as sulphonylureas, biguanides, thiazolidinediones, insulin, alone or in combination, in primary and secondary prevention.

Conditions

  • Diabetes Mellitus, Type 2

Interventions

DRUG

DPP-4 inhibitors

Patients will be retrospectively evaluated after the addition of a DPP-4 inhibitor to previously taken anti-diabetic therapy

Sponsors & Collaborators

  • University of Pavia

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-27
Primary Completion
2020-12-31
Completion
2021-05-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03486964 on ClinicalTrials.gov